ULBI
Ultralife Corporation
6.10$
+2.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 75.2% | 74.4% | 72.6% | 73.1% | 75.7% | 75.8% | 75.7% | 77.0% | 78.8% | 75.7% | 79.3% | 71.1% | 76.1% | |
| 24.8% | 25.6% | 27.4% | 26.9% | 24.3% | 24.2% | 24.3% | 23.0% | 21.2% | 24.3% | 20.7% | 28.9% | 23.9% | |
| 4.7% | 4.2% | 4.2% | 4.6% | 5.9% | 5.5% | 4.0% | 4.0% | 5.7% | 5.3% | 6.2% | 6.7% | 6.0% | |
| 14.6% | 13.2% | 13.5% | 13.1% | 17.0% | 15.3% | 13.7% | 14.5% | 17.8% | 15.8% | 15.5% | 15.0% | 16.0% | |
| 19.3% | 17.4% | 17.7% | 17.8% | 22.9% | 96.6% | 17.6% | 18.4% | 23.4% | 18.6% | 21.2% | 21.8% | 21.2% | |
| 5.4% | 8.2% | 9.7% | 9.1% | 1.4% | 3.4% | 6.7% | 4.6% | -2.2% | 5.7% | -0.5% | 7.2% | 2.7% | |
| 1.5% | 1.3% | 1.2% | 1.0% | 0.5% | 1.9% | 2.0% | 2.0% | 2.3% | 1.9% | 1.8% | 1.7% | 1.9% | |
| 4.4% | 7.0% | 8.6% | 8.9% | 1.0% | 1.1% | 4.8% | 2.3% | -4.0% | -21.1% | -1.4% | 6.2% | -5.1% | |
| 1.1% | 0.6% | 1.7% | 2.0% | 0.2% | – | 1.1% | 0.5% | -1.2% | -5.7% | -0.4% | 1.0% | -1.6% | |
| 3.4% | 6.4% | 6.9% | 6.9% | 0.7% | 0.4% | 3.7% | 1.8% | -2.8% | -15.3% | -1.0% | 5.3% | -3.5% | |
| 8.4% | 10.4% | 12.2% | 12.3% | 4.3% | – | 9.5% | 7.3% | 1.5% | -16.4% | 3.2% | 10.7% | -0.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.